Portal de Periódicos da CAPES

False Positive Multiparametric Magnetic Resonance Imaging Phenotypes in the Biopsy-naïve Prostate: Are They Distinct from Significant Cancer-associated Lesions? Lessons from PROMIS

2020; Elsevier BV; Volume: 79; Issue: 1 Linguagem: Inglês

10.1016/j.eururo.2020.09.043

1873-7560

Vasilis Stavrinides, Tom Syer, Yipeng Hu, Francesco Giganti, Alex Freeman, Solon Karapanagiotis, Simon Bott, Louise Brown, Nicholas Burns‐Cox, Tim Dudderidge, Ahmed El‐Shater Bosaily, Eleni Frangou, Maneesh Ghei, Alastair Henderson, Richard G. Hindley, Richard Kaplan, Robert Oldroyd, Chris Parker, Raj Persad, Derek J. Rosario, Iqbal Shergill, Lina M. Carmona Echeverria, Joseph M. Norris, Mathias Winkler, Dean C. Barratt, Alex Kirkham, Shonit Punwani, Hayley C. Whitaker, Hashim U. Ahmed, Mark Emberton,

Urologic and reproductive health conditions

False positive multiparametric magnetic resonance imaging (mpMRI) phenotypes prompt unnecessary biopsies. The Prostate MRI Imaging Study (PROMIS) provides a unique opportunity to explore such phenotypes in biopsy-naïve men with raised prostate-specific antigen (PSA) and suspected cancer. To compare mpMRI lesions in men with/without significant cancer on transperineal mapping biopsy (TPM). PROMIS participants (n = 235) underwent mpMRI followed by a combined biopsy procedure at University College London Hospital, including 5-mm TPM as the reference standard. Patients were divided into four mutually exclusive groups according to TPM findings: (1) no cancer, (2) insignificant cancer, (3) definition 2 significant cancer (Gleason ≥3 + 4 of any length and/or maximum cancer core length ≥4 mm of any grade), and (4) definition 1 significant cancer (Gleason ≥4 + 3 of any length and/or maximum cancer core length ≥6 mm of any grade). Index and/or additional lesions present in 178 participants were compared between TPM groups in terms of number, conspicuity, volume, location, and radiological characteristics. Most lesions were located in the peripheral zone. More men with significant cancer had two or more lesions than those without significant disease (67% vs 37%; p < 0.001). In the former group, index lesions were larger (mean volume 0.68 vs 0.50 ml; p < 0.001, Wilcoxon test), more conspicuous (Likert 4–5: 79% vs 22%; p < 0.001), and diffusion restricted (mean apparent diffusion coefficient [ADC]: 0.73 vs 0.86; p < 0.001, Wilcoxon test). In men with Likert 3 index lesions, log2PSA density and index lesion ADC were significant predictors of definition 1/2 disease in a logistic regression model (mean cross-validated area under the receiver-operator characteristic curve: 0.77 [95% confidence interval: 0.67–0.87]). Significant cancer-associated MRI lesions in biopsy-naïve men have clinical-radiological differences, with lesions seen in prostates without significant disease. MRI-calculated PSA density and ADC could predict significant cancer in those with indeterminate MRI phenotypes. Magnetic resonance imaging (MRI) lesions that mimic prostate cancer but are, in fact, benign prompt unnecessary biopsies in thousands of men with raised prostate-specific antigen. In this study we found that, on closer look, such false positive lesions have different features from cancerous ones. This means that doctors could potentially develop better tools to identify cancer on MRI and spare some patients from unnecessary biopsies.